Clinical Trials Browser

Phase 1/2 × Recruiting × Cytomegalovirus Infections × Clear all

NCT06909110 2025-08-14

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Phase 1/2 Recruiting

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections